Suppr超能文献

发育中大鼠肠道中胰高血糖素样肽-2受体轴的个体发生

Ontogeny of the glucagon-like peptide-2 receptor axis in the developing rat intestine.

作者信息

Lovshin J, Yusta B, Iliopoulos I, Migirdicyan A, Dableh L, Brubaker P L, Drucker D J

机构信息

Department of Physiology, Toronto General Hospital, Banting and Best Diabetes Center, University of Toronto, Ontario, Canada.

出版信息

Endocrinology. 2000 Nov;141(11):4194-201. doi: 10.1210/endo.141.11.7773.

Abstract

Glucagon-like peptide-2 (GLP-2) is secreted by enteroendocrine cells in the small and large intestines and exerts intestinotropic effects in the gastrointestinal mucosal epithelium of the adult rodent. The actions of GLP-2 are mediated by the GLP-2 receptor, a new member of the G protein-coupled receptor superfamily. To ascertain whether the GLP-2/GLP-2 receptor axis is expressed and functional in the developing intestine, we have studied the synthesis of GLP-2 and the expression of the GLP-2 receptor (GLP-2R) in the fetal and neonatal rat gut. GLP-2 immunoreactivity (GLP-2-IR) was detected in the fetal rat intestine, and fetal rat intestinal cell cultures secreted correctly processed GLP-2(1-33) into the medium. High levels of GLP-2(1-33) were also detected in the circulation of 13-day-old neonatal rats (P < 0.001 vs. adult). Analysis of GLP-2 receptor expression by RT-PCR demonstrated GLP-2R messenger RNA transcripts in fetal intestine and in neonatal stomach, jejunum, ileum, and colon. The levels of GLP-2R messenger RNA transcripts were comparatively higher in the fetal and neonatal intestine (P < 0.05-001 vs. adult) and declined to adult levels by postnatal day 21. Subcutaneous administration of a degradation-resistant GLP-2 analog, h[Gly2]-GLP-2 once daily for 10 days increased stomach (0.009 +/- 0.0003 vs. 0.007 +/- 0.002 g/g body mass, h[Gly2]-GLP-2-treated vs. controls; P < 0.05) and small bowel weight (0.043 +/- 0.0037 vs. 0.031 +/- 0.0030 g/g body mass; P < 0.05). h[Gly2]-GLP-2 also increased both small (2.4 +/- 0.05 vs. 1.8 +/- 0.17 cm/g body mass; P < 0.05) and large bowel length (0.32 +/- 0.01 vs. 0.25 +/- 0.02 cm/g body mass, h[Gly2]-GLP-2-treated vs. saline-treated controls, respectively; P < 0.05) in neonatal rats. These findings demonstrate that both components of the GLP-2/GLP-2 receptor axis are expressed in the fetal and neonatal intestine. The ontogenic regulation and functional integrity of this axis raises the possibility that GLP-2 may play a role in the development and/or maturation of the developing rat intestine.

摘要

胰高血糖素样肽-2(GLP-2)由小肠和大肠的肠内分泌细胞分泌,并在成年啮齿动物的胃肠黏膜上皮发挥促肠生长作用。GLP-2的作用由GLP-2受体介导,该受体是G蛋白偶联受体超家族的新成员。为确定GLP-2/GLP-2受体轴在发育中的肠道是否表达且具有功能,我们研究了胎鼠和新生鼠肠道中GLP-2的合成及GLP-2受体(GLP-2R)的表达。在胎鼠肠道中检测到GLP-2免疫反应性(GLP-2-IR),并且胎鼠肠道细胞培养物将正确加工的GLP-2(1-33)分泌到培养基中。在13日龄新生鼠的循环中也检测到高水平的GLP-2(1-33)(与成年鼠相比,P<0.001)。通过逆转录聚合酶链反应(RT-PCR)分析GLP-2受体表达,结果显示在胎鼠肠道以及新生鼠的胃、空肠、回肠和结肠中存在GLP-2R信使核糖核酸转录物。GLP-2R信使核糖核酸转录物的水平在胎鼠和新生鼠肠道中相对较高(与成年鼠相比,P<0.05 - P<0.001)并且在出生后第21天降至成年水平。每天皮下注射一次抗降解GLP-2类似物h[Gly2]-GLP-2并持续10天可增加胃重量(0.009±0.0003对0.007±0.002 g/g体重;h[Gly2]-GLP-2处理组对对照组;P<0.05)和小肠重量(0.043±0.0037对0.031±0.0030 g/g体重;P<0.05)。h[Gly2]-GLP-2还增加了新生鼠的小肠长度(2.4±0.05对1.8±0.17 cm/g体重;P<0.05)和大肠长度(0.32±0.01对0.25±0.02 cm/g体重;h[Gly2]-GLP-2处理组分别对盐水处理对照组;P<0.05)。这些发现表明GLP-2/GLP-2受体轴的两个组分均在胎鼠和新生鼠肠道中表达。该轴的个体发生调节和功能完整性提示GLP-2可能在新生大鼠肠道的发育和/或成熟中发挥作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验